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TRPC7 Is a Receptor-Operated DAG-Activated
Channel in Human Keratinocytes
Benjamin Beck1,3, Alexander Zholos1,3,4, Vadym Sydorenko1, Morad Roudbaraki1, V’yacheslav Lehen’kyi1,
Pascal Bordat2, Natalia Prevarskaya1,5 and Roman Skryma1,5
Muscarinic and purinergic receptors expressed in keratinocytes are an important part of a functional system for
cell growth. While several aspects of this process are clearly dependent on Ca2þ homeostasis, less is known
about the mechanisms controlling Ca2þ entry during epidermal receptor stimulation. We used patch-clamp
technique to study responses to carbachol (CCh) and adenosine triphosphate (ATP) in HaCaT human
keratinocytes. Both agonists induced large currents mediated by cation-selective channels about three times
more permeable to Ca2þ than Naþ , suggesting that they play an important role in receptor-operated Ca2þ
entry. CCh- and ATP-induced currents were inhibited by 1-[6-([(17b)-3-methoxyestra-1,3,5(10)-trien-17-yl]ami-
no)hexyl]-1H-pyrrole-2,5-dione, a phospholipase C (PLC) blocker. Investigation of the pathways downstream of
PLC activation revealed that InsP3 did not affect the agonist responses. In contrast, 1-oleoyl-2-acetyl-sn-glycerol
(OAG), a membrane-permeable analog of 1,2-diacylglycerol (DAG), evoked a similar cation current. This action
appears to be direct, since the effects of activators or inhibitors of protein kinase C were comparatively small.
Finally, transient receptor potential canonical 7 (TRPC7) specific knockdown by antisense oligonucleotides
led to a decrease in ATP- and CCh-induced calcium entry, as well as OAG-evoked current. We concluded
that activation of both muscarinic and purinergic receptors via a common DAG-dependent link opens
Ca2þ -permeable TRPC7 channels.
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INTRODUCTION
Ca2þ -entry pathways are crucial for skin physiology, as they
play a pivotal role in several aspects of terminal differentia-
tion, such as cell stratification and cornification. Many
studies have shown that inhibition of keratinocyte prolifera-
tion and induction of differentiation depend on an increase in
intracellular Ca2þ concentration ([Ca2þ ]i) due to both Ca
2þ
release and Ca2þ entry (Sharpe et al., 1989; Pillai et al.,
1990; Pillai and Bikle, 1991; Sharpe et al., 1993; Bikle et al.,
1996), but the mechanisms controlling Ca2þ influx in
keratinocytes remain largely unknown, particularly regarding
epidermal G protein-coupled receptor stimulation. Thus, the
keratinocyte plasma membrane is permeable to Ca2þ
(Sharpe et al., 1989; Pillai and Bikle, 1991; Bikle et al.,
1996) and a rise in external Ca2þ concentration (‘calcium
switch’) induces increases in [Ca2þ ]i and cell differentiation.
However, agonist-dependent Ca2þ entry pathways have not
yet been elucidated.
Several Ca2þ -permeable cation channels have been
identified in keratinocytes, notably those activated by
Ca2þ , cyclic guanosine monophosphate, and nicotinic
receptors (Mauro et al., 1993; Grando et al., 1996; Oda
et al., 1997). These channels have been implicated in
epidermal Ca2þ entry mechanisms, while intracellular
Ca2þ release in keratinocytes has been shown to be evoked
by agonists of several receptors coupled to phospholipase C
(PLC) activation and InsP3 formation (Suter et al., 1991; Pillai
and Bikle, 1992; Biro et al., 1998; Koizumi and Ohkawara,
1999; Lee et al., 2001). Store-operated Ca2þ entry may
also be associated with the Ca2þ -releasing action of the
PLC-coupled receptor agonists, as it is induced by treating
keratinocytes with cyclopiazonic acid, thapsigargin, or
phorbol 12-myristate 13-acetate (Jones and Sharpe, 1994a;
Csernoch et al., 2000; Gonczi et al., 2002).
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In addition to the putative store-operated Ca2þ entry
mechanism, there is a possibility that receptor agonists
induce Ca2þ entry by activating Ca2þ -permeable cation
channels via other mechanisms. Transient receptor potential
(TRP) proteins form cation channels, often characterized by a
significant Ca2þ permeability, in a number of cell types. In
nonexcitable cells, these represent a major route of receptor-
mediated Ca2þ entry, either in response to or independently
of Ca2þ store depletion. In the latter case, 1,2-diacylglycerol
(DAG), formed concurrently with InsP3 by PLC activation, is
emerging as an important second messenger that opens
certain types of TRP channels (reviewed by Clapham, 2003).
Thus, in this study, patch-clamp recording techniques and
calcium imaging were used to investigate the membrane
current responses of HaCaT cells, a spontaneously trans-
formed nontumoral epithelial cell line of human adult skin,
to carbachol (CCh) and adenosine triphosphate (ATP). Our
main finding is that both receptor agonists induce transitory
calcium increases as well as large cation currents with
similar biophysical (kinetics, voltage dependence, and ion
selectivity) and pharmacological (sensitivity to the blocking
action of 2-aminoethoxydiphenyl borate (2-APB), SKF-96365,
La3þ , and Ni2þ ) properties. A cation current with very
similar properties was also induced by 1-oleoyl-2-acetyl-sn-
glycerol (OAG), a membrane-permeable analog of DAG,
whereas heparin, InsP3, or protein kinase C (PKC) activity
modulators were ineffective. In the presence of OAG, any
additional agonist-induced response was lost, suggesting that
DAG formation was the main signal transduction pathway
leading to cation channel opening. Reverse transcriptase
(RT)-PCR identified transcripts of several transient receptor
potential canonical (TRPC) channel proteins (TRPC1, TRPC4,
TRPC5, and TRPC7). Moreover, TRPC7 protein down-
expression by antisense oligonucleotides inhibited ATP- and
CCh-induced calcium entry, as well as OAG-evoked current.
Thus, our data demonstrate the existence of receptor-
operated Ca2þ entry in HaCaT cells, which is at least
partially mediated by a DAG-sensitive TRPC7 channel.
RESULTS
Biophysical properties of membrane current responses of
HaCaT cells to ATP and CCh
After establishing whole-cell configuration, the cell was held
at 40 mV. Voltage ramps of 200 ms duration from 100
to 100 mV were applied at 10 s intervals to monitor the
development of the agonist-induced current at different test
potentials. At the maximum response, the voltage depen-
dence and kinetics of the current were examined by applying
500-ms-long voltage steps to test potentials ranging from
100 to 80 mV.
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Figure 1. Activation of purinergic and muscarinic receptors induces cationic current in HaCaT cells. (a) The time course of current development measured at
100 and 100 mV in a HaCaT cell bathed in normal extracellular solution in response to ATP (100 mM, marked by the horizontal bar) and corresponding I–V
relationships measured before and during maximum agonist response. (b) Similar measurements in a different cell exposed to 20 mM CCh. (c) Superimposed
membrane currents evoked by voltage steps applied from a holding potential of 40 mV and ranging from 100 to 80 mV, in control and in the presence of
either ATP or CCh, as indicated. (d) Left panel: Ramp-derived I–V relationships of ATP-evoked currents, measured in divalent cation-free extracellular solution
containing 130 mM Naþ , Csþ , Kþ , or NMDGþ , respectively. Right panel: Ramp-derived I–V relationships of ATP-evoked currents, measured in 130 mM
NMDGþ containing extracellular solution with 10 mM Ca2þ , Mg2þ , or Ba2þ , respectively, as indicated near the traces. Test potentials in all panels were
corrected for liquid junction potential changes as described in Materials and Methods.
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Application of 100mM ATP to HaCaT cells induced a
transmembrane current, which reversed close to 0 mV (Figure
1a) and showed rapid activation and deactivation kinetics on
membrane potential step changes (Figure 1c). A current with
similar reversal potential, amplitude, and kinetics was also
activated by applying 20 mM CCh (Figure 1b and c). Low-Cl
pipette and external solutions were used in these experi-
ments, so any contaminating chloride current would be
significantly reduced. Consistent with this, both ATP- and
CCh-induced currents were insensitive to 5-nitro-2-(3-phenyl-
propylamino)benzoic acid, a common blocker of many types
of chloride channels (data not shown). In contrast, replacing
external Kþ with N-methyl-D-glucamine (NMDGþ ), a large
impermeable cation, virtually abolished the inward current,
suggesting that the agonists activated cation-selective chan-
nels (Figure 1d).
To quantify the relative permeability of several mono-
valent cations through ATP- and CCh-gated cation channels,
we replaced Kþ in the divalent cation-free extracellular
solution with equimolar amounts of Naþ or Csþ . Figure 1d
shows representative current–voltage (I–V) relationships ob-
tained by applying voltage ramps in the presence of 100mM
ATP (Figure 1d) in external solutions containing Naþ , Csþ ,
or Kþ . Test potentials were corrected off-line for liquid
junction potential change as described in Materials and
methods. Comparing the shifts in current reversal potential
(DErev) with the current reversal potential in the presence of
130 mM extracellular Naþ , we obtained the following
relative permeability values (n¼5): PK (3.9870.30)4PCs
(2.7970.26)4PNa (1.0) for ATP-induced current and PK
(3.5070.25)4PCs (2.2770.08)4PNa (1.0) for CCh-induced
current (not illustrated). There was no statistical difference in
the values for the two agonists (P40.1).
We also investigated whether ATP- and CCh-activated
cationic channels were permeable to divalent cations, parti-
cularly Ca2þ . In these experiments, external Kþ was replaced
with impermeable NMDGþ and 10 mM of various divalent
cations tested (Ca2þ , Mg2þ , and Ba2þ ) were added.
Representative I–V relationships of ATP-induced current
responses, measured by applying voltage ramps in the presence
of different divalent cations, are shown in Figure 1d, right
panel. Using equation (2) PX/PCs, permeability ratios were
obtained for different divalent cations (X) and the following
relative divalent cation permeability profiles were calculated
from these values (n¼ 4): PCa (1.0)4PMg (0.7570.06)4PBa
(0.4270.04) for ATP-induced current and PCa (1.0)4PMg
(0.7870.07)4PBa (0.4670.02) for CCh-induced current. Thus,
divalent cation permeability profiles were also the same for
both ATP- and CCh-induced currents (P40.4).
As relative Naþ and Ca2þ permeability through the
channel is most relevant from a physiological standpoint, we
also estimated the PCa/PNa ratio based on the Erev shift
following replacement of NMDGþ -based solution contain-
ing 10 mM Ca2þ with a 130 Naþ , divalent cation-free
solution. These experiments gave the following permeability
ratio (n¼5): PCa/PNa¼2.7770.65 for ATP-induced current.
The permeability ratio PCa/PNa for CCh-induced currents did
not differ significantly (PCa/PNa¼2.4070.75; P40.7).
These results show that both ATP and CCh-induced
cation-selective currents in HaCaT cells have similar biophy-
sical properties. Thus, it is likely that both agonists target the
same Ca2þ -permeable cation channel. To further explore this
hypothesis, we next examined the pharmacological proper-
ties of ATP- and CCh-induced currents.
Pharmacological properties of membrane current responses of
HaCaT cells to ATP and CCh
We examined the effects of several ion-channel blockers:
2-APB, an inhibitor of some store-operated and TRP channel
proteins (Braun et al., 2001; Diver et al., 2001), and SKF-
96365, a common blocker of receptor-operated Ca2þ entry
in nonexcitable cells (Merritt et al., 1990), as well as La3þ
and Ni2þ , inorganic blockers of various cation channels.
2-APB at 100mM significantly inhibited ATP-induced
cationic current in HaCaT cells, that is, by 6074% (n¼ 5).
This block developed rapidly and was completely reversible
(Figure 2a). SKF-96365 (25 mM) inhibited ATP-induced current
by 3273% (Figure 2a and b; n¼ 8). Similar results were
obtained for CCh-evoked cation current (5873 and 2974%
for 100mM 2-APB and 25mM SKF-96365, respectively, n¼ 6;
data not shown). The values were similar for both ATP- and
CCh-induced currents (P40.5).
Ni2þ (100 mM) had no significant effect on either ATP-
induced current (Figure 2b, n¼ 4) or CCh-induced current
(data not shown). La3þ was tested in the concentration range
from 1 mM to 2 mM. Fitting the inhibition curve by the Hill
equation yielded the IC50 value for the blocking action of
La3þ on ATP-induced current of 8676 mM, with a slope
factor in the vicinity of 1 (not illustrated). Figure 2b
summarizes our findings for the inhibitory action of several
common cation channel blockers on the current response
evoked in HaCaT cells by 100 mM ATP.
Signal transduction pathways involved in cation current
generation in response to ATP and CCh
Several subtypes of P2Y purinergic (e.g., P2Y1 and P2Y2) and
muscarinic (M1–M5) receptors are expressed in human
epidermal keratinocytes at high densities (Grando et al.,
1995; Ndoye et al., 1998; Arredondo et al., 2003; Greig
et al., 2003a, b; Chernyavsky et al., 2004). We used several
receptor-specific pharmacological tools to identify the
receptor type involved in the ATP- and CCh-induced
responses. Thus, we investigated the sensitivity of CCh-
evoked Ca2þ entry to atropine – a high-affinity muscarinic
receptor antagonist. Under control conditions, CCh induced
a transitory calcium entry (Figure 2c), which was strongly
inhibited when atropine was added to the medium (50 mM).
This result points to a major involvement of muscarinic
receptors in the CCh-induced calcium response. The ATP-
induced calcium response was inhibited by suramin (100mM),
a well-known P2Y receptor antagonist (Lee et al., 2001), thus
suggesting that P2Y purinergic receptors were involved.
Figure 2d summarizes the results showing the inhibitory
action of atropine and suramin on the calcium responses
evoked in keratinocytes by CCh and ATP (n¼98 and
n¼101), respectively.
1984 Journal of Investigative Dermatology (2006), Volume 126
B Beck et al.
TRP Cation Currents in Human Keratinocytes
Purinergic and odd-numbered muscarinic receptors are
commonly coupled to PLC stimulation, resulting in the
formation of InsP3 and intracellular Ca
2þ store release. The
Ca2þ -releasing effect of several receptor agonists is well
documented in keratinocytes (Suter et al., 1991; Pillai and
Bikle, 1992; Biro et al., 1998; Koizumi and Ohkawara, 1999;
Csernoch et al., 2000; Koegel and Alzheimer, 2001; Lee
et al., 2001). There is also evidence that this effect in
keratinocytes is mediated by the common pathway linking
receptor activation to phosphoinositide metabolism stimula-
tion (Pillai and Bikle, 1992), an effect shown to be inhibited
by 1-[6-([(17b)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino)-
hexyl]-1H-pyrrole-2,5-dione (U-73122), a PLC blocker (Lee
et al., 2001).
In order to reveal the dependence of the agonist-evoked
cation current in HaCaT cells on the signaling cascade
triggered by PLC-catalyzed phosphoinositide turnover, we
used U-73122, while its inactive analog 1-[6-([(17b)-3-
methoxyestra-1,3,5(10)-trien-17-yl]amino)hexyl]-2,5-pyrroli-
dinedione (U-73343) was used in control experiments. U-
73122 (10 mM) nearly completely blocked ATP-evoked
cationic current (Figure 3a), whereas U-73343 had no effect
(not illustrated). In the same manner, we investigated the
action of U-73122 and U-73343 on ATP- and CCh-evoked
Ca2þ entry. Thus, U-73122 strongly inhibited both agonist
Ca2þ responses (86.774.7 and 75.775.8 inhibition, respec-
tively), while U-73343 had no significant action. These
results are summarized in Figure 3b. We further addressed
the possibility that InsP3 could be a second messenger
mediating channel opening either by direct interaction or via
Ca2þ store depletion. Thus, in the next series of experiments,
agonists were applied to cells dialyzed with 100mM InsP3.
Cell dialysis with InsP3 did not evoke any significant cation
current by itself, nor did it affect the time course or maximum
amplitude of the subsequent response to ATP (Figure 3c). Cell
dialysis with heparin (1 mg/ml), an InsP3 receptor blocker,
had no effect on cation current responses to ATP or CCh
either (not illustrated). These results imply that agonist-
induced cation current develops independently of Ca2þ
store depletion, or at least irrespectively of InsP3 production.
It also made it very unlikely that the above-described
inhibitory effect of 2-APB was related to InsP3 receptor
blockade.
DAG is another important intracellular messenger, formed
concurrently with InsP3 during PLC activation. There is
accumulating evidence that DAG can activate cation
channels formed by certain TRP proteins by itself (Hofmann
et al., 1999; Gudermann et al., 2004) and that simultaneous
activation of PKC may also play an important role in DAG-
mediated channel regulation (Venkatachalam et al., 2004).
Thus, we hypothesized that DAG was the second messenger
involved in generating the agonist-evoked cation current in
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Figure 2. Pharmacological properties of ATP-evoked currents in HaCaT cells. (a) Inhibitory effects of 2-APB (100 mM) and SKF-96365 (25 mM) on ATP-induced
inward current measured at 100 mV. (b) Summary of the inhibitory effects of 2-APB (100mM), SKF-96365 (25 mM), La3þ (1 mM), and Ni2þ (100mM) on
ATP-induced current in HaCaT cells (mean7SEM, n¼ 4–8). (c) Inhibition of CCh-induced calcium entry by atropine (50mM). (d) Summary of the inhibitory
effects of atropine (50 mM) and suramin (100 mM) on CCh- and ATP-induced calcium entry in HaCaT cells (mean7SEM, n¼98–101).
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HaCaT cells, possibly via the modulation of PKC activity. To
test this hypothesis, we used OAG, a membrane-permeable
DAG analog. Application of 100 mM OAG to HaCaT cells
following ATP application produced an additional cationic
current (Figure 3d; n¼ 10). Notably, coapplication of ATP
or CCh during maximum OAG-induced response failed
to activate any additional current (Figure 3d and e). The lack
of additive action of OAG and ATP suggests that they
converge on a common signal transduction pathway. Similar
results were obtained for CCh-induced currents, suggesting
that both agonists commonly activate cation channels via
PLC-dependent DAG production.
As DAG is known to activate PKC, we also examined
whether PKC activation contributed to the effect of ATP and
CCh on cation current generation in HaCaT cells. phorbol
12-myristate 13-acetate (100 mM), a membrane-permeable
PKC activator, evoked an inward current that was signifi-
cantly potentiated following ATP application (Figure 4a;
n¼4). Furthermore, OAG-induced current was only slightly
inhibited by 500 nM bisindolylmaleimide, a PKC inhibitor
(Figure 4b; n¼4), but was insensitive to 1 mM staurosporine
(Figure 4c; n¼ 6). These results imply that PKC activation
plays only a minor role in the cation current responses of
HaCaT cells to ATP and CCh. These responses therefore seem
to be largely mediated by DAG alone.
RT-PCR analysis
The results described above prompted us to investigate
whether certain types of TRP channels were present in human
keratinocytes, particularly those of the classical (short) TRPC
family, which share a common PLC-dependent activation
mechanism (Hofmann et al., 1999; Clapham, 2003; Guder-
mann et al., 2004; Venkatachalam et al., 2004). While some
members of this family are believed to open as a result of
Ca2þ store depletion, there is growing evidence that others
may be gated by lipid messengers. Notably, TRPC3, C6, and
C7 form a structurally and functionally related subfamily of
DAG-sensitive channel proteins. As a first step in studying the
molecular identity of the channels mediating agonist-induced
cation current in HaCaT cells, we studied the expression of
the mRNA of the several human TRPC isoforms (TRPC1,
TRPC3, TRPC4, TRPC5, TRPC6, and TRPC7) using specific
primers (Table 1) and the RT-PCR technique. For TRPC1,
TRPC4, and TRPC6, the primers (Table 1) surrounded the
mRNA regions subjected to an alternative splicing generating
the isoforms for these TRPC subtypes. Figure 5 shows the
expression of the TRPC transcripts in HaCaT cells. PCR
products of the expected sizes for TRPC1A (Figure 5a), TRPC4
(Figure 5c), TRPC5 (Figure 5d), and TRPC7 (Figure 5f) were
found in these cells.
These results suggest that TRPC1A, C4 (unspliced form),
C5, and C7 mRNAs are present in HaCaT cells, while TRPC3
and C6 mRNAs were undetectable.
Candidate for DAG-activated current
It is now well established that several TRP channels can be
activated directly by DAG. Among the TRPC subfamily,
TRPC3, TRPC6, and TRPC7 have already been described as
0
–10
–20
Cu
rre
nt
 (p
A/
pF
)
–30
0
InsP3 ATP ATP ATPOAG OAG CCh
–10
–20
Cu
rre
nt
 (p
A/
pF
)
–30
–40
0
0 2
Time (minutes)
4 0
Time (minutes) Time (minutes)
4 8 126 0 2 4 6 8
0 2
Time (minutes)
4 6
ATP U-73122
U-
73
34
3
U-
73
12
2
U-
73
34
3
U-
73
12
2
1,000
500
*
*
0
[C
a2
+ ] c
yt
 
(nM
)
Cch ATP
–10
–20
Cu
rre
nt
 (p
A/
pF
)
–30
–40
–50
0
–10
–20
Cu
rre
nt
 (p
A/
pF
)
–30
–40
–50
c d e
a b
Figure 3. PLC-dependent activation of cation channels involves diacylglycerols, but not InsP3. (a) Inhibition of ATP-induced current (100 mM) by the PLC
blocker U-73122 (10 mM, n¼ 5). Its inactive analog U-73343, applied at the same concentration, had no effect on the current (n¼ 6, not illustrated). (b) Summary
of the effects of U-73122 and its inactive analog U-73343 on CCh- and ATP-evoked calcium entry. (c) InsP3 (100 mM) in the pipette solution did not evoke
any significant current by itself and did not affect cation current generation in response to subsequent application of 100 mM ATP. (d) Application of OAG
(100mM) potentiated ATP-induced current (measured at 100 mV).
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DAG-dependent receptor-operated channels (Gudermann
et al., 2004). Given our results on TRPC channel expression,
TRPC7 appeared to be the sole candidate for the DAG-
activated channel in our model. We therefore used the
antisense oligonucleotide strategy to study the impact of
specific TRPC7 down-expression on ATP- and CCh-evoked
Ca2þ increases, as well as OAG-evoked currrent. This
treatment inhibited TRPC7 translation by 73%, without
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Figure 4. Limited involvement of PKC activation in cation current generation in keratinocytes. (a) Application of PKC activator phorbol 12-myristate
13-acetate induced relatively small cation current in HaCaT cells, while subsequent ATP application (100 mM) evoked approximately two-fold larger current.
(b, c) Minor effects on OAG-induced current of two different PKC blockers, (b) bisindolylmaleimide (Bis-IM, 500 nM; n¼4); and staurosporine
(SP, 1mM, n¼6; c).
Table 1. Sequences of selected oligonucleotides used as RT-PCR primers
Target fragment Oligonucleotide sequences Position in GenBank sequence (Accession no.) Expected size (bp)
hTRPC1 Forward: 50-TTCCTCTCCATCCTCTTCCTCG-30 457–478 (Z73903) 458 (TRPC1)
Backward: 50-CATAGTTGTTACGATGAGCAGC-30 812–791 (Z73903) 356 (TRPC1A)
hTRPC3 Forward: 50-TACTCAACATGCTAATTGCTATGAT-30 2147–2170 (U47050) 383
Backward: 50-CACAGTTGCTTGGCTCTTGTCTTCC-30 2619–2643 (U47050) —
hTRPC4 Forward2: 50-CTCTGGTTGTTCTACTCAACATG-30 2058–2082 (AF063822) 781 (TRPC4)
Backward2: 50-CCTGTTGACGAGCAACTTCTTCT-30 2861–2839 (AF063822) 528 (TRPC4b)
356 (TRPC4d)
332 (TRPC4g)
hTRPC5 Forward: 50-TCAAGTTTATCTGCCACACAGC-30 1322–1343 (NM_016179.1) 417
Backward: 50-TAGGCTCATCGATAGCTCTGGT-30 1879–1858 (NM_016179.1) —
hTRPC6 Forward2: 50-GAACTTAGCAATGAACTGGCAGT-30 1322–1345 (AJ006276) 625 (TRPC6)
Backward2: 50-CATATCATGCCTATTACCCAGGA-30 1947–1925 (AJ006276) 461 (TRPC6b)
277 (TRPC6g)
hTRPC7 Forward: 50-GTCCGAATGCAAGGAAATCT-30 1356–1375 (AJ272034) 477
hTRPC7 Backward: 50-TGGGTTGTATTTGGCACCTC-30 1814–1834 (AJ272034) —
hTRPC6 Forward1: 50-TTCCCGCCATGAGCCAC-30 420–436 (AJ006276) 208
Backward1: 50-CGGTGAGCCAGTCTGTTGTCAGAT-30 627–604 (AJ006276) —
Actin Forward: 50-CAGAGCAAGAGAGGCATCCT-30 248–267 (NM_001101) 210
Backward 50-GTTGAAGGTCTCAAACATGATC-30 457–436 (NM_001101) —
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affecting TRPC1 expression (Figure 6). So, we observed that
TRPC7 down-expression resulted in a smaller increase in
cytoplasmic Ca2þ following purinergic receptor activation
by ATP (Figure 7a). A 2-day TRPC7 antisense oligonucleotide
treatment inhibited ATP-activated Ca2þ response by
47.876.7% (n¼ 105) and CCh-evoked response by
50.8710.6% (n¼101). The results of TRPC7 protein down-
expression on ATP- and CCh-evoked calcium responses are
summarized in Figure 7b. Furthermore, we studied the
consequence of TRPC7 down-expression on OAG-evoked
current to check the pivotal role of DAG in TRPC7 gating. So,
we observed that TRPC7 down-expression resulted in a
smaller OAG activated current (Figure 7c). A 2-day TRPC7
antisense oligonucleotide treatment inhibited OAG-evoked
current by 45.874% (Figure 7d), demonstrating the specific
activation of this channel by DAG produced downstream of
PLC activation.
DISCUSSION
In this study, we showed for the first time that stimulation
of purinergic and muscarinic receptors in HaCaT human
keratinocytes resulted in the generation of sustained cation
currents with similar biophysical and pharmacological
properties. Cation channels mediating this current are about
three times more permeable to Ca2þ than Naþ . These data
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Figure 5. Identification of mRNAs encoding TRPC channel proteins in HaCaT keratinocytes by RT-PCR. Total RNA harvested from HaCaT cells was subjected
to RT after DNase I treatment. PCRs were performed using primers specific for (a) TRPC1A (356 bp), (b) TRPC3 (383 bp), (c) TRPC4 (781 bp), (d) TRPC5 (417 bp),
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Figure 6. Identification of mRNAs encoding TRPC channel proteins in
HaCaT keratinocytes by RT-PCR. Total RNA harvested from HaCaT cells was
subjected to RT after DNase I treatment. PCRs were performed using primers
specific for TRPC1A (356 bp) and TRPC7 (477 bp).
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imply that, under physiological conditions, agonist-induced
cation current can mediate substantial Ca2þ influx, thus
contributing to a further intracellular Ca2þ increase in
addition to that produced by the well-established PLC-
mediated Ca2þ -release (Suter et al., 1991; Pillai and Bikle,
1992; Biro et al., 1998; Koizumi and Ohkawara, 1999;
Csernoch et al., 2000; Koegel and Alzheimer, 2001; Lee
et al., 2001).
Indeed, in HaCaT cells [Ca2þ ]i signals during phosphoi-
nositide agonist action are biphasic: the initial transient
[Ca2þ ]i increase is brought about by InsP3-induced Ca
2þ
release insensitive to external Ca2þ , but the second, more
sustained, phase depends critically on Ca2þ influx. The
second phase was previously attributed to store-operated
Ca2þ entry (Jones and Sharpe, 1994a; Csernoch et al., 2000),
although we have demonstrated the existence of an
additional agonist-activated InsP3-independent Ca
2þ entry
pathway in keratinocytes. It has long been known that, in
keratinocytes, an increase in external Ca2þ induces differ-
entiation associated with a sustained increase in [Ca2þ ]i due
to Ca2þ entry, even in the absence of receptor stimulation.
However, this Ca2þ entry is sensitive to the blocking action
of Ni2þ (Jones and Sharpe, 1994b). In contrast, the agonist-
induced cation current described here was Ni2þ -insensitive
(Figure 2b), indicating that passive and receptor-dependent
Ca2þ entries are mediated by different channels.
In general, the functional role of the purinergic system in
keratinocytes, including ATP-dependent changes in Ca2þ
homeostasis, has been studied more extensively than that of
the cholinergic system. It has, however, been known for
about a decade that human keratinocytes possess cholinergic
enzymes for acetylcholine synthesis and degradation (Grando
et al., 1993) and the more recently demonstrated uptake
of choline by CHT1, a high-affinity choline transporter, at
choline acetyltransferase sites, is expected to promote
acetylcholine synthesis (Pfeil et al., 2003). Human keratino-
cytes are also responsive to acetylcholine, believed to act as a
local hormone in the epidermis (Grando et al., 1993; Grando,
1997).
Several important functions have been attributed to
muscarinic cholinergic receptors in keratinocytes, including
control of cell viability, proliferation, adhesion, migration,
and differentiation (Grando, 1997; Ndoye et al., 1998;
Arredondo et al., 2003; Chernyavsky et al., 2004). Also, the
pattern of muscarinic receptor subtypes expressed in kerati-
nocytes changes completely at each stage in their develop-
ment, suggesting that each receptor subtype may regulate a
specific cell function. Moreover, under pathological condi-
tions, tissue levels of acetylcholine in skin biopsies are greatly
increased (Wessler et al., 2003).
Further studies are needed to establish the precise
mechanisms of acetylcholine action on keratinocytes. It is
assumed that acetylcholine acts via calcium, which acts as
a mediator of its effects in the epidermis (Grando, 1997); yet,
the Ca2þ -releasing effect of CCh appears to be weak
compared to other agonists such as bradykinin, histamine,
or ATP (Biro et al., 1998). Thus, these results substantially
extend our knowledge of Ca2þ metabolism regulation
mechanisms in keratinocytes during the action of acetylcho-
line by demonstrating a novel DAG-dependent Ca2þ entry
pathway triggered by muscarinic receptor stimulation. M1,
M3, or M5 receptors are apparently involved in this effect, as
these are commonly linked to the enhanced PLC-mediated
phospholipid turnover in other cell types (reviewed by
Caulfield and Birdsall, 1998) and these receptor subtypes
are present in epidermal keratinocytes (Ndoye et al., 1998;
Arredondo et al., 2003). It has not yet been established
whether all odd-numbered muscarinic receptor subtypes are
involved, or one specific subtype predominates in cation
current generation in keratinocytes.
P2Y1 and P2Y2 purinergic receptors are also expressed in
keratinocytes at high density and are believed to be part of
a functional signaling system controlling cell proliferation
(Greig et al., 2003a, b). In the epidermis, ATP is released
from platelets during wound healing, potentially exposing
keratinocytes to agonist concentrations sufficient to stimulate
phosphoinositide turnover and evoke InsP3-induced Ca
2þ
release. Although a rise in [Ca2þ ]i during ATP action is well
documented in keratinocytes (Suter et al., 1991; Pillai and
Bikle, 1992; Lee et al., 2001), the possibility of Ca2þ entry in
addition to Ca2þ release triggered by purinergic receptor
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Figure 7. TRPC7 antisense oligonucleotide treatment reduced ATP-induced
calcium responses. (a) Application of ATP induced a transitory calcium
increase in calcium-free medium, which was unaltered by TRPC7
down-expression. In contrast, the calcium increase following calcium
addition to the bath solution was partially inhibited by this treatment, as
shown in a representative example. (b) Comparison of CCh- and
ATP-induced calcium increases under control conditions (sense
oligonucleotides, S TRPC7, n¼ 101) and following 48-hour antisense
treatment (AS TRPC7, n¼ 105). (c) Perfusion of OAG 100 mM activated a
cationic current partially inhibited by TRPC7 antisense oligonucleotides
treatment in two representative cells (sense oligonucleotides, S TRPC7
and antisense oligonucleotides, AS TRPC7). (d) Comparison of
OAG-evoked current under control conditions (sense oligonucleotides,
S TRPC7, n¼ 7) and following 48-hour antisense treatment
(AS TRPC7, n¼ 9).
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stimulation has not yet been addressed. Our current results
strongly imply that there is an ATP-mediated Ca2þ entry
pathway of this type in keratinocytes. Moreover, it shares the
main biophysical and pharmacological characteristics with
the pathway activated by muscarinic receptor stimulation.
We used calcium-imaging experiments and pharmaco-
logical tools such as atropine and suramin to investigate the
type of receptors related to ATP- and CCh-evoked calcium
response. Our findings highlighted the involvement of
P2Y purinergic and M1 muscarinic receptors in ATP- and
CCh-induced calcium entry, respectively. Furthermore, our
experiment using U73122, a specific PLC inhibitor, con-
firmed this first observation, indicating that both types of
receptors are coupled to PLC pathways and, consequently, to
IP3 and DAG synthesis.
Further experiments designed to investigate the underlying
signal transduction pathways showed that the similarities
between cation currents induced by CCh and ATP extended
to the common involvement of PLC activation and down-
stream effects of DAG, but not InsP3 or PKC activation
(Figures 3 and 4). These results imply that the same Ca2þ -
permeable cation channel is targeted by both agonists and,
presumably, other receptor agonists stimulating phosphoino-
sitide turnover in keratinocytes may be capable of opening
this channel.
We hypothesized that DAG-sensitive members of the
novel TRP channel protein family may form the cation
channel activated by phosphoinositide agonists in HaCaT
keratinocytes. Our RT-PCR analysis showed that mRNAs
encoding TRPC1, C4, C5, and C7 were present in HaCaT
cells, while TRPC3 and C6 transcripts were undetectable.
This pattern of TRPC channel expression was different from
the one described in primary cultured keratinocytes (Cai
et al., 2005; Tu et al., 2005). This result highlights a certain
difference between the phenotype of HaCaT cell line and
primary cultures in spite of the ability of HaCaT to undergo
differentiation ‘‘in vitro’’ and ‘‘in vivo’’ like normal keratino-
cytes. As TRPC3, C6, and C7 form a structurally and
functionally related subfamily of channel proteins sensitive
to DAG (Hofmann et al., 1999; Gudermann et al., 2004;
reviewed by Clapham, 2003), TRPC7 may be involved in
ATP- and CCh-induced current generation in HaCaT cells.
Furthermore, TRPC7 specific downexpression by antisense
oligonucleotide strategy inhibited both ATP- and CCh-
activated calcium entry, as well as OAG-evoked current
(Figure 7), pointing to a DAG-dependent activation of TRPC7
in HaCaT cells. A recent study has broadly explored the way
of TRPC7 activation and demonstrated that, depending on the
conditions of TRPC7 overexpression, this channel could be
activated like store-operated channels (SOC) channel or like
receptor-operated channels (Lievremont et al., 2004). The
same group demonstrated that TRPC7 acts like a DAG-
dependent channel when endogenously expressed in B-cells
(Lievremont et al., 2005). Our results on selective TRPC7
knockdown clearly indicate the involvement of this protein in
OAG-activated current in human keratinocytes (Figure 7),
although a significant residual component insensitive to
antisense treatment may indicate either incomplete TRPC7
downregulation, as indicated by RT-PCR results (Figure 6), or
the involvement of other channel proteins. Among the TRPC
channels expressed in primary cultured keratinocytes, some
are known to be structurally very close to TRPC7. So, in
primary cultures, TRPC3 and TRPC6 might be gated in the
same manner as TRPC7 in HaCaT. The same situation has
been observed in prostate cancer epithelial cells; indeed,
while in prostatic cell line, the so-called lymph node
carcinoma of the prostate, DAG-activated current is carried
by TRPC3, the analog current in primary culture is carried by
TRPC6, which is structurally very close to TRPC3 (Thebault
et al., 2003).
The Ca2þ permeability of TRPC7 relative to Naþ is about
one order of magnitude lower (Clapham, 2003) than that in
HaCaT cells, raising the possibility that other TRP proteins
may coassemble to form DAG-sensitive cation channels in
keratinocytes. Interestingly, TRPC1, which appears to be a
store-operated channel when it is expressed in mammalian
cells, is insensitive to Ca2þ store depletion when expressed
in Sf9 cells and shows similarities to the cation current in
HaCaT cells: voltage dependence, Ca2þ selectivity, and
sensitivity to La3þ (Sinkins et al., 1998). Also, heteromers
TRPC1/C5 as well as TRPC1/C3 are cation channels activated
by Gq/PLC-coupled receptors (Strubing et al., 2001) and
DAG (Lintschinger et al., 2000), respectively, but not by of
Ca2þ -store depletion.
In conclusion, this study presents a novel example of a
DAG-sensitive, PKC- and Ca2þ store-insensitive cation current
present in human keratinocytes. The voltage dependence,
pharmacological properties, and gating mechanisms of this
current appear to be very similar to the growing list of its
counterparts in other cell types (Helliwell and Large, 1997;
Tesfai et al., 2001; Jung et al., 2002; Lee et al., 2003; Sydorenko
et al., 2003; Thebault et al., 2003; Trebak et al., 2003).
MATERIALS AND METHODS
Cell culture
HaCaT keratinocytes (kindly provided by CNRS UNR 5543,
Bordeaux) were cultured in (DMEM; Gibko, Paisley, UK) supple-
mented with 10% fetal bovine serum (Seromed, Poly-Labo,
Strasbourg, France). The culture medium contained 0.5 mM CaCl2
and 10 mg/l kanamycine. Cells were grown in 50 ml flasks (Poly-
Labo) and kept at 371C in a humidified incubator in an air/CO2 (95/
5%) atmosphere. For electrophysiology experiments, the cells were
subcultured in Petri dishes (Nunc, France) and used within 3–6 days.
For electrophysiological recordings, the cells were separated by a
brief trypsin treatment (0.1%, 5–7 min) 1 hour before the experiment.
Reverse transcription-PCR analysis
Total RNA from HaCaT cells was isolated by the guanidium
thiocyanate–phenol–chloroform extraction procedure. After a deoxy-
ribonuclease I treatment (0.1 U/ml, 1 hour at 251C; Life Technologies,
Inc., Rockville, MD) to eliminate genomic DNA, total RNA was
reverse transcribed into cDNA as described by Roudbaraki et al.
(1999). Table 1 shows the specific sense and antisense primers used
for the PCR reaction, based on GenBank human TRP (hTRP)
sequences and designed using Genejockey II (Biosoft, Cambridge,
UK). Primers were synthesized by Invitrogen, Paisley, UK.
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Each sample was amplified by Ampli-Taq Gold DNA Polymerase
(Perkin-Elmer, Foster City, CA) in an automated thermal cycler
(GenAmp 2400, Perkin-Elmer). DNA amplification conditions
included an initial 7-minutes denaturation step at 951C (which also
activated the Taq Gold) and 40 cycles of 30 seconds at 951C,
30 seconds at 581C, 40 seconds – 1 minute (depending on the
fragments amplified) at 721C with a final elongation of 7 minutes at
721C. The PCR products were subjected to electrophoresis on a
1.5–2% agarose gel and stained with ethidium bromide (0.5 mg/ml),
then visualized under UV. For identification, each PCR band
was extracted from the gel, then subjected either to restriction
analysis using the specific enzymes for each amplified fragment or
subcloned in TA-cloning vector (Invitrogen) followed by sequencing
analysis.
Antisense assays
For antisense assays, the sense (control) and antisense oligonucleo-
tides (Eurogentec, Seraing, Belgium) targeted at TRPC7 were
designed at the initiating ATG codon level (see Table 1 for
sequences). The HaCaT cells were treated for up to 72 hours with
0.5 mM phosphorothioate antisense or sense oligodeoxynucleotides
by adding them directly to the culture medium. The oligodeoxy-
nucleotides were transfected using Geneporter-2 (Ozyme) in 2 ml
serum-free DMEM-HG.
Patch-clamp recordings
Membrane currents were recorded at room temperature using an
Axopatch 200B patch-clamp amplifier (Axon Instruments Inc., Foster
City, CA). Low-Cl extracellular and intracellular solutions were
used to minimize chloride currents (Galietta et al., 1991; Koegel and
Alzheimer, 2001). The basic extracellular solution contained (in
mM): 130 K-glutamate, 0.5 CaCl2, 1 MgCl2, 10 glucose, 10 HEPES,
and 10 TEAOH, pH adjusted to 7.3 using glutamic acid. Patch
pipettes made of borosilicate glass (resistance 3–5 MO) were filled
with the following solution (in mM): 130 cesium methanesulfonate,
1 MgCl2 (calculated free Mg
2þ concentration: 0.21 mM), 2.5 CaCl2
(calculated free Ca2þ concentration: 150 nM), 10 HEPES, 4 EGTA, 1
Na2ATP, 0.1 Na3GTP, pH adjusted to 7.3 with glutamic acid
(osmolality: 305 mosmol/l). Capacitance and series resistance
(70–80% compensation) but not leak current were compensated
on-line. Current recordings were filtered at 5 kHz and acquired using
a Digidata 1200 interface and pClamp software (Axon Instruments
Inc., Foster City, CA).
To measure currents carried by various monovalent cations,
external Kþ was replaced with equimolar quantities of Naþ , Csþ ,
or NMDGþ . We estimated the permeability of different monovalent
cations through CCh- or ATP-activated channels from the shift of the
reversal potential for Kþ or Csþ currents relative to Naþ current,
DErev, and calculated respective permeability ratios using the
following equation:
PX
PNa
¼ expðDErev  F=R  T Þ ð1Þ
where F, R, and T have their usual meanings. Appropriate liquid
junction potential corrections were applied to the reversal potential
measurements off-line. The values calculated using the pClamp
software were as follows: 2 mV for Kþ -, 4.1 mV for Naþ -, and
2.9 mV for Csþ -based external solution.
Divalent cation permeability was measured in solutions contain-
ing 10 mM CaCl2, BaCl2, or MgCl2, and 120 mM NMDG
þ instead of
K-glutamate. Divalent cation permeability ratios were calculated
from the current reversal potential measured in an external solution
containing a divalent cation (EX), first relative to PCs (equation (2)
below), then by comparing PX/PCs values for different divalent
cations (X):
PX
PCs
¼ ½Cs
þ	i
4  ½X 	O
 expðEX  F=R  T Þ  f1 þ expðEX  F=R  T Þg ð2Þ
where [Csþ ]i is the internal cesium concentration and [X]o is the
external divalent cation X concentration.
The permeability ratio of Ca2þ relative to Naþ was estimated
from the shift of the reversal potential (ECaENa in eq. 3 below) in
solutions containing 130 mM Naþ (Ca2þ -free) or 10 mM Ca2þ (Naþ -
free, NMDGþ substituted) (Kamouchi et al., 1999):
PCa
PNa
¼ ½Na
þ	O
4  ½Ca	O
 expfðECa  ENaÞ  F=R  Tg
 f1 þ expðECa  F=R  T Þg
ð3Þ
where ECa and ENa are current reversal potentials measured with
[Ca]o¼ 10 mM and [Na]o¼ 130 mM, respectively. Osmotic differ-
ences were compensated by adding mannitol in order to adjust the
osmolality of all external solutions to 315 mosmol/l. The EX values
were corrected for liquid junction potential changes, calculated as
described above: 11.8 mV for high-Ca2þ , 12.1 mV for high-Mg2þ ,
and 11.7 mV for high-Ba2þ external solution.
External solutions were changed using a multi-barrel puffing
micropipette with a common outflow positioned in close proximity
to the cell under investigation. During the experiment, the cell was
continuously superfused with the solution via the puffing pipette to
reduce possible artifacts related to the switches from static to moving
solution and vice versa. The external solution was replaced in less
than 1 second.
Data analysis
Data were analyzed and plotted using the pClamp 6 (Axon
Instruments Inc., Foster City, CA) and MicroCal Origin software
(MicroCal Software, Inc., Northampton, MA). Each experiment was
repeated several times and results were expressed as the mean7
SEM. To compare data obtained from different HaCaT cells, current
amplitude was normalized by cell capacitance. In analyzing the time
courses of the currents activated by various agents, the time required
for current to increase by 5% above the baseline level was
considered the latency period and the period when current
amplitude changed from 5–95% of its maximum amplitude was
considered the activation time. Student’s two-tailed t-test was used
for statistical comparison and differences were judged to be
statistically significant when Po0.05.
Calcium imaging
Calcium-imaging experiments were performed as described pre-
viously (Zholos et al., 2005). Briefly, cells were plated onto glass
coverslips and loaded with 4 mM Fura-2 AM at room temperature for
45 minnutes in HBSS containing (in mM): 140 NaCl, 5 KCl, 2 MgCl2,
2 CaCl2, 0.3 Na2HPO3, 0.4 KH2PO4, 4 NaHCO3, 5 glucose, and 10
HEPES adjusted to pH 7.4 with NaOH. For each type of experiment,
data were accumulated from at least three measurements.
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Chemicals
All chemicals were obtained from Sigma (L’Isle d’Abeau Chesnes,
France). ATP, CCh, and 1-[b-[3-(4-methoxyphenyl)propoxy]-4-meth-
oxyphenethyl]-1H-imidazoleHCl (SKF-96365) stock solutions
were prepared in water. OAG, 2-APB, U-73122, U-73343,
staurosporine (SP), and bisindolylmaleimide were prepared in
DMSO or methanol. The final concentration of both solvents in
the experimental solution did not exceed 0.1%.
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